Opinion
A sports device to ‘protect the brain’ illustrates a major problem with the FDA de novo pathway
This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback